EPCAM and breast cancer: In addition to breast cancer tissue, CD44+/CD24−/low/ESA+ cells have also been isolated from breast cancer-derived cell lines with several of such cell lines containing a subset of CD44+/CD24−/low−/EAS+ cells possessing CIC properties such as the capacity for self-renewal [1], [6], [7], [8].